Impact of VIP and cAMP on the regulation of TNF-α and IL-10 production: implications for rheumatoid arthritis

Arthritis Research and Therapy

Volumn 5, Issue 6, 2003, Pages

  Foey, Andrew D ^a   Field, Sarah ^a   Ahmed, Salman ^a   Jain, Abhilash ^a   Feldmann, Marc ^a   Brennan, Fionula M ^a   Williams, Richard ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

IL 10; macrophage; T cells; TNF ; VIP

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; GAMMA INTERFERON; INTERLEUKIN 10; IONOMYCIN; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PROTEIN KINASE C; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MONOCYTE; PATHOLOGY; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ARTHRITIS, RHEUMATOID; BUCLADESINE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; IONOMYCIN; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; PHOSPHODIESTERASE INHIBITORS; PROTEIN KINASE C; ROLIPRAM; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA; VASOACTIVE INTESTINAL PEPTIDE;

EID: 2442595188     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar999     Document Type: Article

References (26)

1. Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Ann Rev Immunol. 1996, 14: 397-440. 10.1146/annurev.immunol.14.1.397. DOI: 10.1146/annurev.immunol.14.1.397
2. Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G: Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNFα and IL-6 release by endotoxin-stimulated macrophages. J Immunol. 1995, 155: 4909-4916.
3. Meisel C, Vogt K, Platzer C, Randow F, Liebenthal C, Volk H-D: Differential regulation of monocytic tumour necrosis factor-a and interleukin-10 expression. Eur J Immunology. 1996, 26: 1580-1586. DOI: 10.1002/eji.1830260726
4. Ross SE, Williams RO, Mason LJ, Mauri C, Marinova-Mutafchieva L, Malfait A-M, Maini RN, Feldmann M: Suppression of TNFα expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. J Immunol. 1997, 159: 6253-6259.
5. Nyman U, Mussener A, Larsson E, Lorentzen J, Klareskog L: Amelioration of collagen II-induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram. Clin Exp Immunol. 1997, 108: 415-419. 10.1046/j.1365-2249.1997.3931291.x. DOI: 10.1046/j.1365-2249.1997.3931291.x
6. Delgado M, Abad C, Martinez C, Leceta J, Gomariz RP: Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med. 2001, 7: 563-568. 10.1038/87887. DOI: 10.1038/87887
7. Williams RO: Therapeutic effect of vasoactive intestinal peptide in collagen-induced arthritis. Arthritis Rheum. 2002, 46: 271-273. 10.1002/1529-0131(200201)46:1<271::AID-ART10039>3.0.CO;2-C. DOI: 10.1002/1529-0131(200201)46:1<271::AID-ART10039>3.0.CO;2-C
8. Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNFα production by macrophages: in vitro and in vivo studies. J Immunol. 1999, 162: 2358-2367.
9. Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP: Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-a and IL-6. J Immunol. 1999, 162: 1200-1205.
10. Delgado M, Munoz-Elias EJ, Kan Y, Gozes I, Fridkin M, Brenneman DE, Gomariz RP, Ganea D: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumour necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun. J Biol Chem. 1998, 273: 31427-31436. 10.1074/jbc.273.47.31427. DOI: 10.1074/jbc.273.47.31427
11. Martinez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. J Leukoc Biol. 1998, 63: 591-601.
12. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D: VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells. J Neuroimmunol. 1999, 96: 167-181. 10.1016/S0165-5728(99)00023-5. DOI: 10.1016/S0165-5728(99)00023-5
13. Delgado M, Ganea D: Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo. J Immunol. 2001, 167: 966-975. DOI: 10.4049/jimmunol.167.2.966
14. Delgado M, Ganea D: Vasoactive intestinal peptide inhibits IL-8 production in human monocytes. Biochem Biophys Res Commun. 2003, 301: 825-832. 10.1016/S0006-291X(03)00059-7. DOI: 10.1016/S0006-291X(03)00059-7
15. Delgado M, Ganea D: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kB and IFN regulatory factor 1 activation. J Immunol. 1991, 162: 4685-4696.
16. Delgado M, Munoz-Elias E, Gomariz RP, Ganea D: Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol. 1999, 162: 1707-1716.
17. Delgado M, Ganea D: Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?. J Immunol. 2001, 166: 2907-2912. DOI: 10.4049/jimmunol.166.5.2907
18. Ganea D: Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv Neuroimmunol. 1996, 6: 61-74. DOI: 10.1016/S0960-5428(96)00007-1
19. Said S: VIP as a modulator of lung inflammation and airway constriction. Am Rev Respir Dis. 1991, 143: 22-24. DOI: 10.1164/ajrccm/143.3_Pt_2.S22
20. Pozo D, Delgado M, Martinez C, Guerrero JM, Leceta J, Gomariz RP, Calvo JR: Immunobiology of vasoactive intestinal peptide (VIP). Immunol Today. 2000, 21: 7-11. 10.1016/S0167-5699(99)01525-X. DOI: 10.1016/S0167-5699(99)01525-X
21. Abrams J, Roncorolo MG, Yssel H, Andersson U, Gleich GJ, Silver J: Strategies and practice of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev. 1992, 127: 5-24. DOI: 10.1111/j.1600-065X.1992.tb01406.x
22. Engelberts I, Moller A, Schoen GJ, van der Linden CJ, Buurmann WA: Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res. 1991, 10: 69-76.
23. Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BMJ, Brennan FM: Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNFα: Role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol. 1998, 160: 920-928.
24. Dewitt D, Gourlet P, Amraoui Z, Vertongen P, Willems F, Robberecht P, Goldman M: The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes. Immunol Lett. 1998, 60: 57-60. 10.1016/S0165-2478(97)00129-6. DOI: 10.1016/S0165-2478(97)00129-6
25. Hernanz A, Tato E, De la Fuente M, de Miguel E, Arnalich F: Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha production by whole blood cells from healthy young and old subjects. J Neuroimmunol. 1996, 71: 25-30. 10.1016/S0165-5728(96)00118-X. DOI: 10.1016/S0165-5728(96)00118-X
26. Foxwell B, Brown K, Bondeson J, Clarke C, de Martin R, Brennan F, Feldmann M: Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumour necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. Proc Natl Acad Sci USA. 1998, 95: 8211-8215. 10.1073/pnas.95.14.8211. DOI: 10.1073/pnas.95.14.8211